These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8474538)

  • 1. Release and disposition of 3H-noradrenaline in the saphenous vein of neonate and adult dogs.
    Moura D; Vaz-da-Silva MJ; Azevedo I; Brandão F; Guimarães S
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):186-91. PubMed ID: 8474538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.
    Caramona MM; Araújo D; Brandão F
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):401-6. PubMed ID: 3921856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of 3H-(--)noradrenaline in the perfused cat and rabbit heart.
    Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):71-82. PubMed ID: 7329455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kinetic study of the release of noradrenaline by electrical stimulation: influence of presynaptic alpha-adrenoceptors.
    Brandão F; Davidson R; Monteiro JG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):248-52. PubMed ID: 2984584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetic characteristics of the extraneuronal Q-methylating system of the dog saphenous vein and the supersensitivity to catecholamines caused by its inhibition.
    Paiva MQ; Guimarães S
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):48-55. PubMed ID: 6493350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deamination of released 3H-noradrenaline in the canine saphenous vein.
    Verbeuren TJ; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):148-57. PubMed ID: 7063044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites.
    Muldoon SM; Vanhoutte PM; Tyce GM
    Am J Physiol; 1978 Mar; 234(3):H235-43. PubMed ID: 629360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue accumulation and release of newly synthesized 3H-dopamine and 3H-noradrenaline in canine saphenous veins incubated with 3H-(--)-tyrosine.
    Boels PJ; Verbeuren TJ; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):7-14. PubMed ID: 6633679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fate of [3H]-(-)-noradrenaline in the perfused rat liver.
    Martel F; Azevedo I
    J Auton Pharmacol; 1995 Oct; 15(5):309-19. PubMed ID: 8744971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery.
    Branco D; Caramona M; Martel F; de Almeida JA; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):286-93. PubMed ID: 1407015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of norepinephrine during nerve stimulation in dog saphenous vein.
    Rorie DK; Muldoon SM; Tyce GM
    Am J Physiol; 1980 Aug; 239(2):H238-46. PubMed ID: 7406060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the metabolic fate of noradrenaline released by electrical stimulation or by tyramine.
    Brandão F; Monteiro JG; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):37-40. PubMed ID: 723969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of [3H]-noradrenaline in human dental pulp in vitro.
    Parker DA; de la Lande IS; Marino V; Proctor CH; Ivar PM; Parker I
    Arch Oral Biol; 1994 Jan; 39(1):43-9. PubMed ID: 8179507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.
    Caramona MM; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.
    Fitzgerald JL; Reid JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):313-23. PubMed ID: 8097569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of progesterone on the metabolism of noradrenaline in rabbit uterine endometrium and myometrium.
    Kennedy JA; de la Lande IS
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):368-76. PubMed ID: 3774017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraneuronal uptake of noradrenaline in rabbit dental pulp: evidence of identity with uptake1.
    Marino V; de la Lande IS; Parker DA; Dally J; Wing S
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):166-72. PubMed ID: 1448181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and metabolism of 3H-(+/-)-noradrenaline in the isolated perfused rat liver.
    Steinberg P; Acevedo C; Masana MI; Rubio MC
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):392-6. PubMed ID: 3405314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.
    Molderings GJ; Colling E; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1994 Mar; 111(3):733-8. PubMed ID: 8019753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between the neuronal handling of 3H-7- and 3H-7,8-(-)noradrenaline: implications for the release of the labelled neurotransmitter by nerve stimulation.
    Henseling M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):129-35. PubMed ID: 2882429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.